Usage Information

Monoclonal antibody characterization of a chymotrypsin-like molecule on neutrophil membrane associated with cellular activation.
C H King, C H Goralnik, P J Kleinhenz, J A Marino, J R Sedor, A A Mahmoud
C H King, C H Goralnik, P J Kleinhenz, J A Marino, J R Sedor, A A Mahmoud
View: Text | PDF
Research Article

Monoclonal antibody characterization of a chymotrypsin-like molecule on neutrophil membrane associated with cellular activation.

Abstract

Monoclonal antibody 1-15 (Ab 1-15), is a murine anti-human neutrophil (PMN) IgG1 that inhibits PMN effector responses to N-formyl-met-leu-phe (FMLP) and phorbol myristate acetate. In this study, the effects of Ab 1-15 on PMN membrane-related functions were characterized: Ab 1-15 inhibited PMN superoxide (O-2) response to FMLP by 60% (P less than 0.005) without effect on the onset or duration of O-2 production. This inhibition of O-2 response was associated with a significant inhibition of PMN chymotrypsin-like, but not trypsin-like, protease activity. Cell fractionation studies indicated the presence of an Ab 1-15 inhibitable, chymotryptic neutral protease activity in PMN membranes. In studies of Ab 1-15 effects on membrane-related second messenger pathways, Ab 1-15 augmented both FMLP- and isoproterenol-induced intracellular cAMP accumulation, whereas alpha-chymotrypsin decreased PMN cAMP response to these stimuli. Our data suggest that the function-inhibiting, anti-PMN monoclonal Ab 1-15 defines a PMN chymotryptic enzyme on the membrane surface that is involved in regulation of two membrane-related functions, O-2 generation and cAMP generation.

Authors

C H King, C H Goralnik, P J Kleinhenz, J A Marino, J R Sedor, A A Mahmoud

×

Usage data is cumulative from February 2025 through February 2026.

Usage JCI PMC
Text version 133 4
PDF 62 4
Scanned page 267 0
Citation downloads 64 0
Totals 526 8
Total Views 534
(Click and drag on plot area to zoom in. Click legend items above to toggle)

Usage information is collected from two different sources: this site (JCI) and Pubmed Central (PMC). JCI information (compiled daily) shows human readership based on methods we employ to screen out robotic usage. PMC information (aggregated monthly) is also similarly screened of robotic usage.

Various methods are used to distinguish robotic usage. For example, Google automatically scans articles to add to its search index and identifies itself as robotic; other services might not clearly identify themselves as robotic, or they are new or unknown as robotic. Because this activity can be misinterpreted as human readership, data may be re-processed periodically to reflect an improved understanding of robotic activity. Because of these factors, readers should consider usage information illustrative but subject to change.

Advertisement